These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22087177)

  • 1. Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings.
    Khosravi S; Alavian SM; Zare A; Daryani NE; Fereshtehnejad SM; Daryani NE; Keramati MR; Abdollahzade S; Taba Taba Vakili S
    Hepat Mon; 2011 Jun; 11(6):452-8. PubMed ID: 22087177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease.
    Thong VD; Quynh BTH
    Int J Gen Med; 2021; 14():1349-1355. PubMed ID: 33889015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study.
    Lin MS; Lin HS; Chung CM; Lin YS; Chen MY; Chen PH; Hu JH; Chou WN; Huang JC; Huang TJ
    BMJ Open; 2015 Sep; 5(9):e008797. PubMed ID: 26369802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings.
    Daryani NE; Daryani NE; Alavian SM; Zare A; Fereshtehnejad SM; Keramati MR; Pashaei MR; Habibollahi P
    World J Gastroenterol; 2010 Sep; 16(33):4169-75. PubMed ID: 20806434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience.
    Rath MM; Panigrahi MK; Pattnaik K; Bhuyan P; Kar SK; Misra B; Misra D; Meher C; Agrawal O; Rath J; Singh SP
    J Clin Exp Hepatol; 2016 Dec; 6(4):291-296. PubMed ID: 28003718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease.
    Fallatah HI; Akbar HO; Fallatah AM
    Hepat Mon; 2016 Jul; 16(7):e38346. PubMed ID: 27642348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease.
    Jamali R; Hatami N; Kosari F
    Hepat Mon; 2016 May; 16(5):e37412. PubMed ID: 27313636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease.
    Mandal A; Bhattarai B; Kafle P; Khalid M; Jonnadula SK; Lamicchane J; Kanth R; Gayam V
    Cureus; 2018 Nov; 10(11):e3626. PubMed ID: 30697502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.
    Yoneda M; Imajo K; Eguchi Y; Fujii H; Sumida Y; Hyogo H; Ono M; Suzuki Y; Kawaguchi T; Aoki N; Sata M; Kanemasa K; Kohgo Y; Saibara T; Chayama K; Itoh Y; Yoshikawa T; Anzai K; Fujimoto K; Okanoue T; Nakajima A;
    J Gastroenterol; 2013 Sep; 48(9):1051-60. PubMed ID: 23184095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients.
    Khodadoostan M; Shariatifar B; Motamedi N; Abdolahi H
    Adv Biomed Res; 2016; 5():40. PubMed ID: 27099853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
    McPherson S; Anstee QM; Henderson E; Day CP; Burt AD
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):652-8. PubMed ID: 23325287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease.
    Koplay M; Gulcan E; Ozkan F
    J Investig Med; 2011 Oct; 59(7):1137-40. PubMed ID: 21804402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
    Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
    Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT): the correlation of value with underlying severity of alcoholic liver disease.
    Gurung RB; Purbe B; Gyawali P; Risal P
    Kathmandu Univ Med J (KUMJ); 2013; 11(43):233-6. PubMed ID: 24442172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of Persistently Elevated Alanine Aminotransferase Levels in Patients who Presented to Two Referral Hospitals in Mashhad, Iran during 2011.
    Khorashad A; Vossoughinia H; Saadatnia H; Esmaelzadeh A; Ahadi M; Farzanehfar MR; Hosseini SM; Afzalaghaii M; Amirmajdi E; Barari L; Saadatnia F
    Middle East J Dig Dis; 2014 Jan; 6(1):18-22. PubMed ID: 24829700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.